SCHEMBL67227

SCHEMBL67227

CCOC([O])OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866328 0.83
SCHEMBL3588077 0.77
SCHEMBL8990992 0.73
SCHEMBL4394182 0.73
SCHEMBL5424388 0.71
SCHEMBL4390917 0.71
SCHEMBL3297413 0.69
SCHEMBL6161595 0.69
SCHEMBL6355264 0.69
SCHEMBL3579303 0.67 CYP3A4 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115304513-A Chalcone derivative with anti-inflammatory activity and synthesis method and application thereof 湖北科技学院 2022-11-08 CN claimed
US-20160145197-A1 PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES ABBVIE INC. 2016-05-26 US claimed
EP-2870132-A1 PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES AbbVie Inc. (US) 2015-05-13 EP claimed
US-20140012015-A1 PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES ABBVIE INC. 2014-01-09 US claimed
WO-2014008350-A1 PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES ABBVIE INC. (US) 2014-01-09 WO claimed
US-20130303549-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF GALDERMA RES & DEV (FR) 2013-11-14 US claimed
US-8513297-B2 Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2013-08-20 US claimed
US-20120121527-A1 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF GALDERMA RESEARCH & DEVELOPMENT (FR) 2012-05-17 US claimed
US-8129416-B2 Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2012-03-06 US claimed
US-20110184173-A1 Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity THE KITASATO INSTITUTE (JP) 2011-07-28 US claimed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP claimed
EP-0700914-A1 Camptothecin derivatives, preparations thereof and antitumor agents KABUSHIKI KAISHA YAKULT HONSHA (JP) 1996-03-13 EP claimed
EP-0656356-A1 DIOXACYCLOALKANE COMPOUND WITH RENIN-INHIBITING ACTIVITY JAPAN TOBACCO INC. (JP) 1995-06-07 EP claimed
US-5411737-A Flea and tick collars MERCK & CO., INC. (US) 1995-05-02 US claimed
US-5245034-A Compound having vessel smooth muscle relaxation activity Hidaka, Kiroyoshi (JP) 1993-09-14 US claimed
EP-0396065-A1 Novel amino acid derivatives possessing renin-inhibitory activities Japan Tobacco Inc. (JP) 1990-11-07 EP claimed
US-4929637-A CARBONIC ANHYDRASE INHIBITORS, VISION DEFECTS MERCK & CO., INC. (US) 1990-05-29 US claimed
EP-0228237-B1 SUBSTITUTED THIOPHENE-2-SULFONAMIDE ANTIGLAUCOMA AGENTS MERCK & CO. INC. (US) 1989-11-23 EP claimed
EP-0228237-A1 Substituted thiophene-2-sulfonamide antiglaucoma agents MERCK & CO. INC. (US) 1987-07-08 EP claimed
US-4174345-A TREATMENT OF STEROL ETHERS WITH ZINC BROMIDE IN METHYLENE CHLORIDE KAISER EMIL T 1979-11-13 US claimed